{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:56:15Z","timestamp":1784141775613,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019719","name":"Chiesi Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019717","name":"AstraZeneca Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019718","name":"Boehringer Ingelheim Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.opresp.2022.100181","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:06:38Z","timestamp":1652727998000},"page":"100181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory Patient"],"prefix":"10.1016","volume":"4","author":[{"given":"Felipe","family":"Villar-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"de la Rosa-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Fari\u00f1as-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Jim\u00e9nez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.opresp.2022.100181_bib0320","doi-asserted-by":"crossref","first-page":"100097","DOI":"10.1016\/j.opresp.2021.100097","article-title":"Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias","volume":"3","author":"Villar-\u00c1lvarez","year":"2021","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2022.100181_bib0325","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.chest.2018.09.003","article-title":"The aging lung","volume":"155","author":"Bowdish","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2022.100181_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41541-021-00354-z","article-title":"Vaccination as a preventative measure contributing to immune fitness","volume":"6","author":"Laup\u00e8ze","year":"2021","journal-title":"NPJ Vac"},{"key":"10.1016\/j.opresp.2022.100181_bib0335","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflammaging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.opresp.2022.100181_bib0340","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/gerona\/glab136","article-title":"The immunity clock","volume":"76","author":"Mart\u00ednez de Toda","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.opresp.2022.100181_bib0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.maturitas.2021.02.006","article-title":"The twilight of the immune system: the impact of immunosenescence in aging","volume":"147","author":"Feehan","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.opresp.2022.100181_bib0350","doi-asserted-by":"crossref","first-page":"100208","DOI":"10.1016\/j.lanepe.2021.100208","article-title":"Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study","volume":"10","author":"Naaber","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.opresp.2022.100181_bib0355","doi-asserted-by":"crossref","first-page":"692546","DOI":"10.1155\/2015\/692546","article-title":"The impact of immunosenescence on pulmonary disease","volume":"2015","author":"Murray","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.opresp.2022.100181_bib0360","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaci.2010.08.011","article-title":"Age-related changes in immune function: effect on airway inflammation","volume":"126","author":"Busse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.opresp.2022.100181_bib0365","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3349\/ymj.2019.60.5.407","article-title":"COPD as a disease of immunosenescence","volume":"60","author":"Cho","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.opresp.2022.100181_bib0370","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/thoraxjnl-2014-206084","article-title":"Accelerated ageing of the lung in COPD: new concepts","volume":"70","author":"Mercado","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.opresp.2022.100181_bib0375","doi-asserted-by":"crossref","first-page":"111551","DOI":"10.1016\/j.exger.2021.111551","article-title":"Accelerated immunosenescence, oxidation and inflammation lead to a higher biological age in COPD patients","volume":"154","author":"Mat\u00e9","year":"2021","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.opresp.2022.100181_bib0380","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3390\/ijms22126214","article-title":"Cellular senescence: pathogenic mechanisms in lung fibrosis","volume":"22","author":"Parimon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.opresp.2022.100181_bib0385","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-2600(13)70165-6","article-title":"Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions","volume":"2","author":"Krone","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2022.100181_bib0390","doi-asserted-by":"crossref","first-page":"108857","DOI":"10.1016\/j.clim.2021.108857","article-title":"A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults","volume":"232","author":"Shin","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.opresp.2022.100181_bib0395","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3389\/fimmu.2019.02247","article-title":"Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention","volume":"10","author":"Aiello","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.opresp.2022.100181_bib0400","unstructured":"Fari\u00f1as F. En defensa propia: aventuras y desventuras del sistema inmunol\u00f3gico. Amazing Books; N.\u00b0 1 edici\u00f3n (1 April 2017). ASIN: B06XWF24CG."},{"key":"10.1016\/j.opresp.2022.100181_bib0405","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/nu9060624","article-title":"Zinc in infection and inflammation","volume":"9","author":"Gammoh","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.opresp.2022.100181_bib0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10522-006-9057-3","article-title":"Correlation between zinc status and immune function in the elderly","volume":"7","author":"Haase","year":"2006","journal-title":"Biogerontology"},{"key":"10.1016\/j.opresp.2022.100181_bib0415","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of vitamin D on human health and disease","volume":"12","author":"Charoenngam","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.opresp.2022.100181_bib0420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1465-9921-15-53","article-title":"Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity","volume":"15","author":"Pletz","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.opresp.2022.100181_bib0425","doi-asserted-by":"crossref","first-page":"e0222313","DOI":"10.1371\/journal.pone.0222313","article-title":"The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review","volume":"14","author":"Fisher","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.opresp.2022.100181_bib0430","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2014.07.003","article-title":"Influence of the microbiota on vaccine effectiveness","volume":"35","author":"Valdez","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.opresp.2022.100181_bib0435","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-019-0177-9","article-title":"Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?","volume":"19","author":"Duggal","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.opresp.2022.100181_bib0440","doi-asserted-by":"crossref","first-page":"M557","DOI":"10.1093\/gerona\/57.9.M557","article-title":"Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals","volume":"57","author":"Kohut","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.opresp.2022.100181_bib0445","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00010.2018","article-title":"The sleep-immune crosstalk in health and disease","volume":"99","author":"Besedovsky","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.opresp.2022.100181_bib0450","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI95149","article-title":"Strategies targeting cellular senescence","volume":"128","author":"Ovadya","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.opresp.2022.100181_bib0455","doi-asserted-by":"crossref","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","article-title":"Senescent cell clearance by the immune system: emerging therapeutic opportunities","volume":"40","author":"Prata","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.opresp.2022.100181_bib0460","article-title":"Manual de Inmunosenescencia. Envejecimiento. Inmunidad y vacunas","author":"Fari\u00f1as","year":"2022","journal-title":"Amazing Books"},{"key":"10.1016\/j.opresp.2022.100181_bib0465","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.drudis.2017.01.004","article-title":"Therapeutic interventions for aging: the case of cellular senescence","volume":"22","author":"Soto-Gamez","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.opresp.2022.100181_bib0470","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2022 report. Available from: https:\/\/goldcopd.org\/2022-gold-reports-2\/ [accessed January 2022]."},{"key":"10.1016\/j.opresp.2022.100181_bib0475","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbres.2021.03.005","article-title":"Spanish COPD Guidelines (GesEPOC) 2021: updated pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2022","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.opresp.2022.100181_bib0480","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. Available fom: https:\/\/ginasthma.org\/wp-content\/uploads\/2021\/05\/GINA-Main-Report-2021-V2-WMS.pdf [accessed February 2022]."},{"key":"10.1016\/j.opresp.2022.100181_bib0485","unstructured":"CDC. Lung Disease including Asthma and Adult Vaccination. Available from: https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/health-conditions\/lung-disease.html [accessed February 2022]."},{"key":"10.1016\/j.opresp.2022.100181_bib0490","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1700153","article-title":"Influenza vaccine effectiveness in the United States during the 2015\u20132016 season","volume":"377","author":"Jackson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2022.100181_bib0495","doi-asserted-by":"crossref","first-page":"30602","DOI":"10.2807\/1560-7917.ES.2017.22.34.30602","article-title":"The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013\/14 and 2014\/15","volume":"22","author":"Dom\u00ednguez","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.opresp.2022.100181_bib0500","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2016.11.013","article-title":"Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis","volume":"35","author":"Young","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.opresp.2022.100181_bib0505","unstructured":"CDC. Pneumococcal vaccination: summary of who and when to vaccinate. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/who-when-to-vaccinate.html [accessed February 2022]."},{"key":"10.1016\/j.opresp.2022.100181_bib0510","first-page":"CD001390","article-title":"Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease","volume":"1","author":"Walters","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.opresp.2022.100181_bib0515","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"issue":"S1","key":"10.1016\/j.opresp.2022.100181_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arbres.2020.01.014","article-title":"Community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) guidelines. 2020 update","volume":"56","author":"Men\u00e9ndez","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2022.100181_bib0525","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults","author":"Lewnard","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0530","first-page":"jiab128","article-title":"Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract","author":"Lewnard","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0535","first-page":"e141088","article-title":"Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine","volume":"6","author":"Carniel","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.opresp.2022.100181_bib0540","unstructured":"Vaxneuvance. Ficha t\u00e9cnica. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vaxneuvance-epar-product-information_es.pdf [accessed February 2022]."},{"key":"10.1016\/j.opresp.2022.100181_bib0545","unstructured":"Apexxnar. Ficha t\u00e9cnica. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/apexxnar-epar-product-information_es.pdf [accessed February 2022]."},{"key":"10.1016\/j.opresp.2022.100181_bib0550","first-page":"ciab990","article-title":"Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults 18 years and older","author":"Essink","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0555","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.vaccine.2021.08.049","article-title":"A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)","volume":"40","author":"Platt","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.opresp.2022.100181_bib0560","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/ciab307","article-title":"The evolution and distribution of pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Spain using a serotype-specific urinary antigen detection test: the CAPA study, 2011\u20132018","volume":"73","author":"Torres","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0565","doi-asserted-by":"crossref","first-page":"e3778","DOI":"10.1093\/cid\/ciaa1483","article-title":"Nationwide trends of invasive pneumococcal disease in Spain from 2009 through 2019 in children and adults during the pneumococcal conjugate vaccine era","volume":"73","author":"de Miguel","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0570","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vacun.2021.05.001","article-title":"SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseases","volume":"22","author":"de la Rosa-Carrillo","year":"2021","journal-title":"Vacunas"},{"key":"10.1016\/j.opresp.2022.100181_bib0575","doi-asserted-by":"crossref","unstructured":"Ortiz de Lejarazu y Leonardo R. Future of vaccination against SARS-CoV-2 infection. Open Respiratory Archives 2021;2:100117.","DOI":"10.1016\/j.opresp.2021.100117"},{"key":"10.1016\/j.opresp.2022.100181_bib0580","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.arbres.2021.06.008","article-title":"Whooping cough: the visible enemy","volume":"58","author":"Gonz\u00e1lez-Barcala","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2022.100181_bib0585","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the advisory committee on immunization practices \u2013 United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.opresp.2022.100181_bib0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2021.100153","article-title":"Pertussis vaccine in COPD and asthma: an old acquaintance is back","volume":"4","author":"Villar-\u00c1lvarez","year":"2022","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2022.100181_bib0595","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.opresp.2022.100181_bib0600","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/ofid\/ofaa439.069","article-title":"Economic burden of herpes zoster among individuals with chronic obstructive pulmonary disease: a retrospective cohort study","volume":"7","author":"Ghaswalla","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0605","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2022.100181_bib0610","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2022.100181_bib0615","first-page":"ciab629","article-title":"The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase III clinical trials (ZOE-50 and ZOE-70)","author":"Boutry","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2022.100181_bib0620","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1080\/21645515.2019.1627818","article-title":"Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials","volume":"15","author":"Oostvogels","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.opresp.2022.100181_bib0625","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the advisory committee on immunization practices \u2013 United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.opresp.2022.100181_bib0630","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40266-015-0258-9","article-title":"Respiratory syncytial virus infection in older adults: an under-recognized problem","volume":"32","author":"Branche","year":"2015","journal-title":"Drugs Aging"}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663622000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663622000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:14:03Z","timestamp":1762938843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2659663622000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2659663622000273"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2022.100181","relation":{},"ISSN":["2659-6636"],"issn-type":[{"value":"2659-6636","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory Patient","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2022.100181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100181"}}